The United States government (USG) is the world's largest funder of product development for global health, but as we show in this report, its funding for such research and development (R&D) is in decline. The report aims to identify opportunities to strengthen USG's role in supporting global health product development. It does so by examining the landscape of USG funding for such global health R&D; describing catalysts and barriers to increasing USG funding and coordination of global health R&D; providing perspectives from both USG and private actors (e.g. industry and foundations); and proposing initial ideas for reform.

The final report is due to be published in February, 2017

The report aims to inform future USG policy on global health R&D, with a focus on product development.